IQVIA Holdings Inc (IQV)

$199.06 -$1.18 (-0.59%) 4:38 PM 12/13/24
NYSE | $USD | Diagnostics & Research

Stock Data

  • Market Cap

    $36.78B
  • Day's Range

    $198.00 - $200.91
  • Volume

    1,387,824
  • 52 Week Low / High

    $187.62 - $261.73
  • PE Ratio

    26.59x
  • PEG Ratio

    1.05
  • Dividend Frequency

    -

IQV's Dividend
-
Amount
-
Dividend Yield
-
Payment Date
-
Annual Dividend Amount
Dividend Streak
Hypothetical 10k Investment Jan 1, 2020
Capital Growth
Dividend Return to Date
Dividend Payout year Est.
Expenses
Total Return
Total Return %
Analyists Ranking
14
Strong Buy
7
Buy
4
Hold
0
Sell
0
Strong Sell
$247.22
Target Price

Company News

  • A 12-Year-Old’s Journey Into the World of Ozempic — Nov 24th, 2024

    A mother found success with a weight-loss drug after a lifelong battle. Noticing her young daughter start down the same path, she decided to have her try semaglutide, the active ingredient in Wegovy and Ozempic. Continue reading View comments...

  • IQVIA to Announce Third-Quarter 2024 Results on October 31, 2024 — Oct 15th, 2024

    RESEARCH TRIANGLE PARK, N.C., October 15, 2024--(BUSINESS WIRE)--IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV) will announce its third-quarter 2024 financial results before the market opens on Thursday, October 31, 2024. The IQVIA management team will also host a conference call and webcast at ...

  • Here's Why IQVIA Holdings (IQV) is a Strong Value Stock — Oct 4th, 2024

    For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Achieving those goals is made easier with the Zacks Style Scores, a unique set of guidelines that rates stocks based on popular investing methodologies, namely value, growt...

  • Here's Why You Should Retain IQVIA Holdings Shares Now — Oct 4th, 2024

    IQVIA Holdings Inc. IQV has had an impressive run over the past three months. The stock has gained 9.3%, outperforming the 3.9% rise of the industry it belongs to and the Zacks S&P 500 composite’s 2% uptick. IQV has an expected long-term (three to five years) EPS growth rate of 10.4%. T...

  • Jerome Dodson's Strategic Moves in Q3 2024 Highlight JB Hunt Transport Services Inc — Oct 10th, 2024

    Insight into the Investment Shifts of a Renowned Value Investor Jerome Dodson (Trades, Portfolio), the founder and chairman of Parnassus Investments, has made significant portfolio adjustments in the third quarter of 2024. Known for his ethical investment philosophy, Dodson focuses on mid...

  • Jerome Dodson's Strategic Moves in Q3 2024 Highlight JB Hunt Transport Services Inc — Oct 10th, 2024

    Insight into the Investment Shifts of a Renowned Value Investor Jerome Dodson (Trades, Portfolio), the founder and chairman of Parnassus Investments, has made significant portfolio adjustments in the third quarter of 2024. Known for his ethical investment philosophy, Dodson focuses on mid...

  • A 12-Year-Old’s Journey Into the World of Ozempic — Nov 24th, 2024

    A mother found success with a weight-loss drug after a lifelong battle. Noticing her young daughter start down the same path, she decided to have her try semaglutide, the active ingredient in Wegovy and Ozempic. Continue reading View comments...

  • A 12-Year-Old’s Journey Into the World of Ozempic — Nov 24th, 2024

    A mother found success with a weight-loss drug after a lifelong battle. Noticing her young daughter start down the same path, she decided to have her try semaglutide, the active ingredient in Wegovy and Ozempic. Continue reading View comments...

  • A 12-Year-Old’s Journey Into the World of Ozempic — Nov 24th, 2024

    A mother found success with a weight-loss drug after a lifelong battle. Noticing her young daughter start down the same path, she decided to have her try semaglutide, the active ingredient in Wegovy and Ozempic. Continue reading View comments...

  • Here's Why You Should Retain IQVIA Holdings Shares Now — Oct 4th, 2024

    IQVIA Holdings Inc. IQV has had an impressive run over the past three months. The stock has gained 9.3%, outperforming the 3.9% rise of the industry it belongs to and the Zacks S&P 500 composite’s 2% uptick. IQV has an expected long-term (three to five years) EPS growth rate of 10.4%. T...

  • A 12-Year-Old’s Journey Into the World of Ozempic — Nov 24th, 2024

    A mother found success with a weight-loss drug after a lifelong battle. Noticing her young daughter start down the same path, she decided to have her try semaglutide, the active ingredient in Wegovy and Ozempic. Continue reading View comments...

  • IQVIA to Announce Third-Quarter 2024 Results on October 31, 2024 — Oct 15th, 2024

    RESEARCH TRIANGLE PARK, N.C., October 15, 2024--(BUSINESS WIRE)--IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV) will announce its third-quarter 2024 financial results before the market opens on Thursday, October 31, 2024. The IQVIA management team will also host a conference call and webcast at ...

  • A 12-Year-Old’s Journey Into the World of Ozempic — Nov 24th, 2024

    A mother found success with a weight-loss drug after a lifelong battle. Noticing her young daughter start down the same path, she decided to have her try semaglutide, the active ingredient in Wegovy and Ozempic. Continue reading View comments...

  • Here's Why You Should Retain IQVIA Holdings Shares Now — Oct 4th, 2024

    IQVIA Holdings Inc. IQV has had an impressive run over the past three months. The stock has gained 9.3%, outperforming the 3.9% rise of the industry it belongs to and the Zacks S&P 500 composite’s 2% uptick. IQV has an expected long-term (three to five years) EPS growth rate of 10.4%. T...

  • Here's Why IQVIA Holdings (IQV) is a Strong Value Stock — Oct 4th, 2024

    For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Achieving those goals is made easier with the Zacks Style Scores, a unique set of guidelines that rates stocks based on popular investing methodologies, namely value, growt...

  • Jerome Dodson's Strategic Moves in Q3 2024 Highlight JB Hunt Transport Services Inc — Oct 10th, 2024

    Insight into the Investment Shifts of a Renowned Value Investor Jerome Dodson (Trades, Portfolio), the founder and chairman of Parnassus Investments, has made significant portfolio adjustments in the third quarter of 2024. Known for his ethical investment philosophy, Dodson focuses on mid...

  • IQVIA to Announce Third-Quarter 2024 Results on October 31, 2024 — Oct 15th, 2024

    RESEARCH TRIANGLE PARK, N.C., October 15, 2024--(BUSINESS WIRE)--IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV) will announce its third-quarter 2024 financial results before the market opens on Thursday, October 31, 2024. The IQVIA management team will also host a conference call and webcast at ...

  • Jerome Dodson's Strategic Moves in Q3 2024 Highlight JB Hunt Transport Services Inc — Oct 10th, 2024

    Insight into the Investment Shifts of a Renowned Value Investor Jerome Dodson (Trades, Portfolio), the founder and chairman of Parnassus Investments, has made significant portfolio adjustments in the third quarter of 2024. Known for his ethical investment philosophy, Dodson focuses on mid...

  • Here's Why You Should Retain IQVIA Holdings Shares Now — Oct 4th, 2024

    IQVIA Holdings Inc. IQV has had an impressive run over the past three months. The stock has gained 9.3%, outperforming the 3.9% rise of the industry it belongs to and the Zacks S&P 500 composite’s 2% uptick. IQV has an expected long-term (three to five years) EPS growth rate of 10.4%. T...

  • Jerome Dodson's Strategic Moves in Q3 2024 Highlight JB Hunt Transport Services Inc — Oct 10th, 2024

    Insight into the Investment Shifts of a Renowned Value Investor Jerome Dodson (Trades, Portfolio), the founder and chairman of Parnassus Investments, has made significant portfolio adjustments in the third quarter of 2024. Known for his ethical investment philosophy, Dodson focuses on mid...

  • Here's Why You Should Retain IQVIA Holdings Shares Now — Oct 4th, 2024

    IQVIA Holdings Inc. IQV has had an impressive run over the past three months. The stock has gained 9.3%, outperforming the 3.9% rise of the industry it belongs to and the Zacks S&P 500 composite’s 2% uptick. IQV has an expected long-term (three to five years) EPS growth rate of 10.4%. T...

  • Jerome Dodson's Strategic Moves in Q3 2024 Highlight JB Hunt Transport Services Inc — Oct 10th, 2024

    Insight into the Investment Shifts of a Renowned Value Investor Jerome Dodson (Trades, Portfolio), the founder and chairman of Parnassus Investments, has made significant portfolio adjustments in the third quarter of 2024. Known for his ethical investment philosophy, Dodson focuses on mid...

  • A 12-Year-Old’s Journey Into the World of Ozempic — Nov 24th, 2024

    A mother found success with a weight-loss drug after a lifelong battle. Noticing her young daughter start down the same path, she decided to have her try semaglutide, the active ingredient in Wegovy and Ozempic. Continue reading View comments...

  • Here's Why You Should Retain IQVIA Holdings Shares Now — Oct 4th, 2024

    IQVIA Holdings Inc. IQV has had an impressive run over the past three months. The stock has gained 9.3%, outperforming the 3.9% rise of the industry it belongs to and the Zacks S&P 500 composite’s 2% uptick. IQV has an expected long-term (three to five years) EPS growth rate of 10.4%. T...

  • A 12-Year-Old’s Journey Into the World of Ozempic — Nov 24th, 2024

    A mother found success with a weight-loss drug after a lifelong battle. Noticing her young daughter start down the same path, she decided to have her try semaglutide, the active ingredient in Wegovy and Ozempic. Continue reading View comments...

  • A 12-Year-Old’s Journey Into the World of Ozempic — Nov 24th, 2024

    A mother found success with a weight-loss drug after a lifelong battle. Noticing her young daughter start down the same path, she decided to have her try semaglutide, the active ingredient in Wegovy and Ozempic. Continue reading View comments...

  • Here's Why IQVIA Holdings (IQV) is a Strong Value Stock — Oct 4th, 2024

    For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Achieving those goals is made easier with the Zacks Style Scores, a unique set of guidelines that rates stocks based on popular investing methodologies, namely value, growt...

  • Here's Why IQVIA Holdings (IQV) is a Strong Value Stock — Oct 4th, 2024

    For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Achieving those goals is made easier with the Zacks Style Scores, a unique set of guidelines that rates stocks based on popular investing methodologies, namely value, growt...

  • Here's Why You Should Retain IQVIA Holdings Shares Now — Oct 4th, 2024

    IQVIA Holdings Inc. IQV has had an impressive run over the past three months. The stock has gained 9.3%, outperforming the 3.9% rise of the industry it belongs to and the Zacks S&P 500 composite’s 2% uptick. IQV has an expected long-term (three to five years) EPS growth rate of 10.4%. T...

  • Here's Why You Should Retain IQVIA Holdings Shares Now — Oct 4th, 2024

    IQVIA Holdings Inc. IQV has had an impressive run over the past three months. The stock has gained 9.3%, outperforming the 3.9% rise of the industry it belongs to and the Zacks S&P 500 composite’s 2% uptick. IQV has an expected long-term (three to five years) EPS growth rate of 10.4%. T...

  • Here's Why IQVIA Holdings (IQV) is a Strong Value Stock — Oct 4th, 2024

    For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Achieving those goals is made easier with the Zacks Style Scores, a unique set of guidelines that rates stocks based on popular investing methodologies, namely value, growt...

  • A 12-Year-Old’s Journey Into the World of Ozempic — Nov 24th, 2024

    A mother found success with a weight-loss drug after a lifelong battle. Noticing her young daughter start down the same path, she decided to have her try semaglutide, the active ingredient in Wegovy and Ozempic. Continue reading View comments...

  • Here's Why IQVIA Holdings (IQV) is a Strong Value Stock — Oct 4th, 2024

    For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Achieving those goals is made easier with the Zacks Style Scores, a unique set of guidelines that rates stocks based on popular investing methodologies, namely value, growt...

  • IQVIA to Announce Third-Quarter 2024 Results on October 31, 2024 — Oct 15th, 2024

    RESEARCH TRIANGLE PARK, N.C., October 15, 2024--(BUSINESS WIRE)--IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV) will announce its third-quarter 2024 financial results before the market opens on Thursday, October 31, 2024. The IQVIA management team will also host a conference call and webcast at ...

  • Here's Why IQVIA Holdings (IQV) is a Strong Value Stock — Oct 4th, 2024

    For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Achieving those goals is made easier with the Zacks Style Scores, a unique set of guidelines that rates stocks based on popular investing methodologies, namely value, growt...

  • Here's Why You Should Retain IQVIA Holdings Shares Now — Oct 4th, 2024

    IQVIA Holdings Inc. IQV has had an impressive run over the past three months. The stock has gained 9.3%, outperforming the 3.9% rise of the industry it belongs to and the Zacks S&P 500 composite’s 2% uptick. IQV has an expected long-term (three to five years) EPS growth rate of 10.4%. T...

  • Here's Why IQVIA Holdings (IQV) is a Strong Value Stock — Oct 4th, 2024

    For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Achieving those goals is made easier with the Zacks Style Scores, a unique set of guidelines that rates stocks based on popular investing methodologies, namely value, growt...

  • A 12-Year-Old’s Journey Into the World of Ozempic — Nov 24th, 2024

    A mother found success with a weight-loss drug after a lifelong battle. Noticing her young daughter start down the same path, she decided to have her try semaglutide, the active ingredient in Wegovy and Ozempic. Continue reading View comments...

  • IQVIA to Announce Third-Quarter 2024 Results on October 31, 2024 — Oct 15th, 2024

    RESEARCH TRIANGLE PARK, N.C., October 15, 2024--(BUSINESS WIRE)--IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV) will announce its third-quarter 2024 financial results before the market opens on Thursday, October 31, 2024. The IQVIA management team will also host a conference call and webcast at ...

  • A 12-Year-Old’s Journey Into the World of Ozempic — Nov 24th, 2024

    A mother found success with a weight-loss drug after a lifelong battle. Noticing her young daughter start down the same path, she decided to have her try semaglutide, the active ingredient in Wegovy and Ozempic. Continue reading View comments...

  • A 12-Year-Old’s Journey Into the World of Ozempic — Nov 24th, 2024

    A mother found success with a weight-loss drug after a lifelong battle. Noticing her young daughter start down the same path, she decided to have her try semaglutide, the active ingredient in Wegovy and Ozempic. Continue reading View comments...

  • Jerome Dodson's Strategic Moves in Q3 2024 Highlight JB Hunt Transport Services Inc — Oct 10th, 2024

    Insight into the Investment Shifts of a Renowned Value Investor Jerome Dodson (Trades, Portfolio), the founder and chairman of Parnassus Investments, has made significant portfolio adjustments in the third quarter of 2024. Known for his ethical investment philosophy, Dodson focuses on mid...

  • Jerome Dodson's Strategic Moves in Q3 2024 Highlight JB Hunt Transport Services Inc — Oct 10th, 2024

    Insight into the Investment Shifts of a Renowned Value Investor Jerome Dodson (Trades, Portfolio), the founder and chairman of Parnassus Investments, has made significant portfolio adjustments in the third quarter of 2024. Known for his ethical investment philosophy, Dodson focuses on mid...

  • Here's Why IQVIA Holdings (IQV) is a Strong Value Stock — Oct 4th, 2024

    For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Achieving those goals is made easier with the Zacks Style Scores, a unique set of guidelines that rates stocks based on popular investing methodologies, namely value, growt...

  • IQVIA Announces IQVIA AI Assistant, Powered by IQVIA Healthcare-grade AI™ — Oct 2nd, 2024

    RESEARCH TRIANGLE PARK, N.C., October 02, 2024--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today introduces IQVIA AI Assistant, a generative AI t...

  • A 12-Year-Old’s Journey Into the World of Ozempic — Nov 24th, 2024

    A mother found success with a weight-loss drug after a lifelong battle. Noticing her young daughter start down the same path, she decided to have her try semaglutide, the active ingredient in Wegovy and Ozempic. Continue reading View comments...

  • IQVIA to Announce Third-Quarter 2024 Results on October 31, 2024 — Oct 15th, 2024

    RESEARCH TRIANGLE PARK, N.C., October 15, 2024--(BUSINESS WIRE)--IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV) will announce its third-quarter 2024 financial results before the market opens on Thursday, October 31, 2024. The IQVIA management team will also host a conference call and webcast at ...

  • IQVIA to Announce Third-Quarter 2024 Results on October 31, 2024 — Oct 15th, 2024

    RESEARCH TRIANGLE PARK, N.C., October 15, 2024--(BUSINESS WIRE)--IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV) will announce its third-quarter 2024 financial results before the market opens on Thursday, October 31, 2024. The IQVIA management team will also host a conference call and webcast at ...

  • IQVIA to Announce Third-Quarter 2024 Results on October 31, 2024 — Oct 15th, 2024

    RESEARCH TRIANGLE PARK, N.C., October 15, 2024--(BUSINESS WIRE)--IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV) will announce its third-quarter 2024 financial results before the market opens on Thursday, October 31, 2024. The IQVIA management team will also host a conference call and webcast at ...

  • A 12-Year-Old’s Journey Into the World of Ozempic — Nov 24th, 2024

    A mother found success with a weight-loss drug after a lifelong battle. Noticing her young daughter start down the same path, she decided to have her try semaglutide, the active ingredient in Wegovy and Ozempic. Continue reading View comments...

Similar Stocks

Want to be notified on dividend changes?

Start manging your portfolio today.

Sign up for free